Rosie O’Donnell says Mounjaro is part of why she’s ‘never felt better’ at 64
Rosie O'Donnell said losing weight had always been difficult for her, even when she was actively trying to do so.
Rosie O'Donnell, at 64, declared she has never felt better, crediting the weight loss drug Mounjaro. The actress and talk show host shared her experience on the Good Hang with Amy Poehler podcast. O'Donnell first tried the medication three years ago to manage her diabetes. While her doctor focused on reducing her blood sugar numbers, she unexpectedly shed pounds.
During a celebratory dinner for her son's engagement, she noticed her appetite had vanished, initially attributing it to emotions regarding her late mother. Two weeks later, she feared something was wrong after losing 12 pounds without trying. O'Donnell attributed her weight loss to tirzepatide, the active ingredient in Mounjaro and Zepbound, a GLP-1 hormone activator.
This drug, approved by the FDA in 2022, works similarly to Ozempic and Wegovy, activating GLP-1 and GIP receptors. O'Donnell is among several celebrities who have publicly discussed their GLP-1 medication experiences.
Written by urgent.news from Business Insider's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
